Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire9 October 2025
InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025…
Read More » -
Cision PR Newswire9 October 2025
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics,…
Read More » -
Cision PR Newswire9 October 2025
Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics,…
Read More » -
Cision PR Newswire9 October 2025
Chartis Research and Metrika Release Comprehensive Framework for Managing Digital Asset Risk
New Report Introduces ‘Integrated Composability Risk’ (ICR) – A Novel Risk Category for Digital Assets and Blockchains NEW YORK, Oct.…
Read More » -
Cision PR Newswire9 October 2025
Chartis Research and Metrika Release Comprehensive Framework for Managing Digital Asset Risk
New Report Introduces ‘Integrated Composability Risk’ (ICR) – A Novel Risk Category for Digital Assets and Blockchains NEW YORK, Oct.…
Read More » -
Cision PR Newswire9 October 2025
Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
ADCE-D01 is a first-in-class antibody-drug conjugate targeting uPARAP, an endocytic receptor highly overexpressed in mesenchymal cancers including multiple soft tissue sarcoma…
Read More » -
Cision PR Newswire9 October 2025
Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
ADCE-D01 is a first-in-class antibody-drug conjugate targeting uPARAP, an endocytic receptor highly overexpressed in mesenchymal cancers including multiple soft tissue sarcoma…
Read More » -
Cision PR Newswire9 October 2025
Deepki Launches the Deepki Index: The Gold Standard in Sustainability Benchmarking for U.S. Commercial Real Estate
A Robust Benchmark Giving Real Estate Leaders Clarity, Confidence, and Comparability NEW YORK, Oct. 9, 2025 /PRNewswire/ — Deepki, the…
Read More » -
Cision PR Newswire9 October 2025
Deepki Launches the Deepki Index: The Gold Standard in Sustainability Benchmarking for U.S. Commercial Real Estate
A Robust Benchmark Giving Real Estate Leaders Clarity, Confidence, and Comparability NEW YORK, Oct. 9, 2025 /PRNewswire/ — Deepki, the…
Read More » -
Cision PR Newswire9 October 2025
Penguin Location Services is Recognized with Patient Experience Excellence Award at the International PX Congress
IRVINE, Calif., Oct. 9, 2025 /PRNewswire/ — Penguin Location Services, a leader in real-time location intelligence, is proud to announce…
Read More »







